Cavazzana, M., Schmidt, M., & Kalle, C. v. (2014). Study Hgb-205: Outcomes of gene therapy for hemoglobinopathies via transplantation of autologous hematopoietic stem cells Transduced ex vivo with a lentiviral beta(A-T87Q)-globin vector (LentiGlobin (R) BB305 drug product). Blood, 124(21), .
Chicago-Zitierstil (17. Ausg.)Cavazzana, Marina, Manfred Schmidt, und Christof von Kalle. "Study Hgb-205: Outcomes of Gene Therapy for Hemoglobinopathies via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta(A-T87Q)-globin Vector (LentiGlobin (R) BB305 Drug Product)." Blood 124, no. 21 (2014).
MLA-Zitierstil (9. Ausg.)Cavazzana, Marina, et al. "Study Hgb-205: Outcomes of Gene Therapy for Hemoglobinopathies via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta(A-T87Q)-globin Vector (LentiGlobin (R) BB305 Drug Product)." Blood, vol. 124, no. 21, 2014.